{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:41:23Z","timestamp":1791268883838,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP-114997"],"award-info":[{"award-number":["MOP-114997"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP-2455048"],"award-info":[{"award-number":["MOP-2455048"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Foundation of the Quebec Heart and Lung Institute"},{"name":"Eli Lilly Canada"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jcmg.2014.09.016","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T12:15:45Z","timestamp":1414844145000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Impact of Plasma Lp-PLA2 Activity on\u00a0the\u00a0Progression of Aortic Stenosis"],"prefix":"10.1016","volume":"8","author":[{"given":"Romain","family":"Capoulade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ablajan","family":"Mahmut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Tastet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Arsenault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lisabeth","family":"B\u00e9dard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean G.","family":"Dumesnil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Despr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Larose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit J.","family":"Arsenault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan","family":"Boss\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Pibarot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2014.09.016_bib1","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","article-title":"Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease-2011 update","volume":"124","author":"Rajamannan","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2014.09.016_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/ATVBAHA.107.154989","article-title":"Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis","volume":"28","author":"Mohty","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijcard.2009.05.054","article-title":"Oxidized low-density lipoprotein, angiotensin II and increased waist circumference are associated with valve inflammation in prehypertensive patients with aortic stenosis","volume":"145","author":"C\u00f4t\u00e9","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/hrt.2007.125740","article-title":"Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis","volume":"94","author":"C\u00f4t\u00e9","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jcmg.2014.09.016_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.mol.0000174155.61307.5f","article-title":"Lipoprotein-associated phospholipase A2 as a target of therapy","volume":"16","author":"Macphee","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jacc.2013.05.105","article-title":"Elevated expression of Lp-PLA2 in calcific aortic valve disease: implication for valve mineralization","volume":"63","author":"Mahmut","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib7","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1515\/cclm-2012-0015","article-title":"Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis","volume":"50","author":"Kolasa-Trela","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jcmg.2014.09.016_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM200008313430903","article-title":"Predictors of outcome in severe, asymptomatic aortic stenosis","volume":"343","author":"Rosenhek","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2014.09.016_bib9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jacc.2009.04.079","article-title":"Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis","volume":"54","author":"Hachicha","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib10","doi-asserted-by":"crossref","first-page":"e1000928","DOI":"10.1371\/journal.pgen.1000928","article-title":"Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study","volume":"6","author":"Suchindran","year":"2010","journal-title":"PLoS Genet"},{"issue":"Pt 2","key":"10.1016\/j.jcmg.2014.09.016_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/bj3380479","article-title":"Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor","volume":"338","author":"Macphee","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.jcmg.2014.09.016_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-006-9280-x","article-title":"Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells","volume":"295","author":"Aiyar","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jcmg.2014.09.016_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.coph.2005.11.008","article-title":"Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target","volume":"6","author":"Macphee","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/hrt.2005.066852","article-title":"Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?","volume":"92","author":"Newby","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jcmg.2014.09.016_bib15","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.amjcard.2008.04.056","article-title":"Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis","volume":"102","author":"Antonini-Canterin","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib16","doi-asserted-by":"crossref","first-page":"H5","DOI":"10.1152\/ajpheart.00824.2009","article-title":"Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology","volume":"298","author":"Rajamannan","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/01.ATV.0000255952.47980.c2","article-title":"Aortic valve calcification: determinants and progression in the population","volume":"27","author":"Messika-Zeitoun","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.ATV.16.4.523","article-title":"Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis","volume":"16","author":"O'Brien","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib19","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1161\/01.CIR.0000035655.45453.D2","article-title":"Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma","volume":"106","author":"O'Brien","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2014.09.016_bib20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMra1313875","article-title":"Aortic-valve stenosis\u2013from patients at risk to severe valve obstruction","volume":"371","author":"Otto","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2014.09.016_bib21","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/eurheartj\/ehs450","article-title":"Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients\u2013the COFRASA study","volume":"34","author":"Hekimian","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2014.09.016_bib22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCIMAGING.113.001508","article-title":"18F-NaF uptake Is a marker of active calcification and disease progression in patients with aortic stenosis","volume":"7","author":"Dweck","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2014.09.016_bib23","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.jacc.2005.12.073","article-title":"Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis","volume":"47","author":"Briand","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jacc.2012.03.052","article-title":"Impact of metabolic syndrome on progression of aortic stenosis: Influence of age and statin therapy","volume":"60","author":"Capoulade","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib25","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.105.598086","article-title":"Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis","volume":"113","author":"Katz","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2014.09.016_bib26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/db08-1515","article-title":"Relationship of metabolic syndrome to incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"58","author":"Katz","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jcmg.2014.09.016_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijcard.2008.12.068","article-title":"Age-related differences in the pathogenesis of calcific aortic stenosis: the potential role of resistin","volume":"142","author":"Mohty","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000327588","article-title":"Hypoadiponectinemia is associated with valvular inflammation and faster disease progression in patients with aortic stenosis","volume":"118","author":"Mohty","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.jcmg.2014.09.016_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0021-9150(92)90255-F","article-title":"Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size","volume":"93","author":"Tribble","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jcmg.2014.09.016_bib30","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1161\/hc4401.098490","article-title":"Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease","volume":"104","author":"St Pierre","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2014.09.016_bib31","first-page":"199","article-title":"The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects","volume":"25","author":"Lamarche","year":"1999","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcmg.2014.09.016_bib32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacc.2012.04.038","article-title":"Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies","volume":"60","author":"Tsimikas","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib33","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1161\/ATVBAHA.112.251306","article-title":"Mechanisms of lipoprotein(a) pathogenicity: prothrombotic, proatherosclerotic, or both?","volume":"32","author":"Spence","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2014.09.016_bib36","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jacc.2013.08.1639","article-title":"New therapeutic targets for calcific aortic valve stenosis: the lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidized phospholipid axis","volume":"63","author":"Hung","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib37","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A\u00a0randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2014.09.016_bib38","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2014.09.016_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis. Results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2014.09.016_bib40","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.amjcard.2010.07.042","article-title":"Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study)","volume":"106","author":"Gerdts","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib41","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.2353\/ajpath.2010.090541","article-title":"Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via toll-like receptor 2","volume":"176","author":"Derbali","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib42","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.biocel.2007.12.001","article-title":"Visceral obesity and the heart","volume":"40","author":"Mathieu","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jcmg.2014.09.016_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/clpt.2009.311","article-title":"Obesity, inflammation, and cardiovascular risk","volume":"87","author":"Mathieu","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jcmg.2014.09.016_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/eurheartj\/ehn502","article-title":"Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study","volume":"30","author":"Tsimikas","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2014.09.016_bib45","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1056\/NEJMoa1315878","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease","volume":"370","author":"White","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2014.09.016_bib46","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial","volume":"312","author":"O'Donoghue","year":"2014","journal-title":"JAMA"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X14008584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X14008584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:41:29Z","timestamp":1761846089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X14008584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1936878X14008584"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2014.09.016","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Plasma Lp-PLA2 Activity on\u00a0the\u00a0Progression of Aortic Stenosis","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2014.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}